XAIR (Beyond Air) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


XAIR Beyond Air Inc XAIR
27 GF Score
Price $0.49
GF Value $9.75
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Beyond Air Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Beyond Air's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


XAIR vs LUDG, INBS, FEED: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Beyond Air's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beyond Air Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Beyond Air's Margin of Safety % (DCF Earnings Based) falls into.


XAIR
27GF Score
Beyond Air Inc XAIR
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beyond Air (XAIR) Overvalued in 2026?

Based on GuruFocus' analysis, Beyond Air stock appears to be undervalued. The current stock price of $0.49 is trading 95% below its estimated GF Value™ of $9.75. GuruFocus considers Beyond Air to be Possible Value Trap.

Key valuation signals for XAIR:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $9.75 vs. price of $0.49 (95% below fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the XAIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beyond Air Business Description

Address 900 Stewart Avenue, Suite 301, Garden City, New York, NY, USA, 11530
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
27GF Score

Get the complete analysis for XAIR

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.49
Price
$9.75
GF Value